Report Detail
Global Cell and Gene Supply Chain Solutions Market Growth (Status and Outlook) 2023-2029
- RnM4527597 |
- 07 April, 2023 |
- Global |
- 124 Pages |
- LPI(LP Information) |
- Service & Software
The global Cell and Gene Supply Chain Solutions market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell and Gene Supply Chain Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell and Gene Supply Chain Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell and Gene Supply Chain Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell and Gene Supply Chain Solutions players cover Arvato, Biocair, CSafe Global, LLC, Catalent, BioLife Solutions, BioTherapies, Azenta US, Inc., Clarkston Consulting and Cryoport, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
LPI (LP Information)' newest research report, the “Cell and Gene Supply Chain Solutions Industry Forecast” looks at past sales and reviews total world Cell and Gene Supply Chain Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Supply Chain Solutions sales for 2023 through 2029. With Cell and Gene Supply Chain Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Supply Chain Solutions industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Supply Chain Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Supply Chain Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Supply Chain Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Supply Chain Solutions and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Supply Chain Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Supply Chain Solutions market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cloud-Based
On-Premises
Segmentation by application
Biobank/ Cell-bank
Hospitals
Research Institutes
Cell Therapy Labs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Arvato
Biocair
CSafe Global, LLC
Catalent
BioLife Solutions
BioTherapies
Azenta US, Inc.
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
MAK-SYSTEM International Group
MasterControl, Inc.
SAP
SAVSU Technologies, Inc.
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink, Inc.
TrakCel Limited
Vineti, Inc
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cell and Gene Supply Chain Solutions Market Size 2018-2029
- 2.1.2 Cell and Gene Supply Chain Solutions Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Cell and Gene Supply Chain Solutions Segment by Type
- 2.2.1 Cloud-Based
- 2.2.2 On-Premises
- 2.3 Cell and Gene Supply Chain Solutions Market Size by Type
- 2.3.1 Cell and Gene Supply Chain Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Cell and Gene Supply Chain Solutions Market Size Market Share by Type (2018-2023)
- 2.4 Cell and Gene Supply Chain Solutions Segment by Application
- 2.4.1 Biobank/ Cell-bank
- 2.4.2 Hospitals
- 2.4.3 Research Institutes
- 2.4.4 Cell Therapy Labs
- 2.4.5 Others
- 2.5 Cell and Gene Supply Chain Solutions Market Size by Application
- 2.5.1 Cell and Gene Supply Chain Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Cell and Gene Supply Chain Solutions Market Size Market Share by Application (2018-2023)
3 Cell and Gene Supply Chain Solutions Market Size by Player
- 3.1 Cell and Gene Supply Chain Solutions Market Size Market Share by Players
- 3.1.1 Global Cell and Gene Supply Chain Solutions Revenue by Players (2018-2023)
- 3.1.2 Global Cell and Gene Supply Chain Solutions Revenue Market Share by Players (2018-2023)
- 3.2 Global Cell and Gene Supply Chain Solutions Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cell and Gene Supply Chain Solutions by Regions
- 4.1 Cell and Gene Supply Chain Solutions Market Size by Regions (2018-2023)
- 4.2 Americas Cell and Gene Supply Chain Solutions Market Size Growth (2018-2023)
- 4.3 APAC Cell and Gene Supply Chain Solutions Market Size Growth (2018-2023)
- 4.4 Europe Cell and Gene Supply Chain Solutions Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Cell and Gene Supply Chain Solutions Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Cell and Gene Supply Chain Solutions Market Size by Country (2018-2023)
- 5.2 Americas Cell and Gene Supply Chain Solutions Market Size by Type (2018-2023)
- 5.3 Americas Cell and Gene Supply Chain Solutions Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Cell and Gene Supply Chain Solutions Market Size by Region (2018-2023)
- 6.2 APAC Cell and Gene Supply Chain Solutions Market Size by Type (2018-2023)
- 6.3 APAC Cell and Gene Supply Chain Solutions Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Cell and Gene Supply Chain Solutions by Country (2018-2023)
- 7.2 Europe Cell and Gene Supply Chain Solutions Market Size by Type (2018-2023)
- 7.3 Europe Cell and Gene Supply Chain Solutions Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Cell and Gene Supply Chain Solutions by Region (2018-2023)
- 8.2 Middle East & Africa Cell and Gene Supply Chain Solutions Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Cell and Gene Supply Chain Solutions Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Cell and Gene Supply Chain Solutions Market Forecast
- 10.1 Global Cell and Gene Supply Chain Solutions Forecast by Regions (2024-2029)
- 10.1.1 Global Cell and Gene Supply Chain Solutions Forecast by Regions (2024-2029)
- 10.1.2 Americas Cell and Gene Supply Chain Solutions Forecast
- 10.1.3 APAC Cell and Gene Supply Chain Solutions Forecast
- 10.1.4 Europe Cell and Gene Supply Chain Solutions Forecast
- 10.1.5 Middle East & Africa Cell and Gene Supply Chain Solutions Forecast
- 10.2 Americas Cell and Gene Supply Chain Solutions Forecast by Country (2024-2029)
- 10.2.1 United States Cell and Gene Supply Chain Solutions Market Forecast
- 10.2.2 Canada Cell and Gene Supply Chain Solutions Market Forecast
- 10.2.3 Mexico Cell and Gene Supply Chain Solutions Market Forecast
- 10.2.4 Brazil Cell and Gene Supply Chain Solutions Market Forecast
- 10.3 APAC Cell and Gene Supply Chain Solutions Forecast by Region (2024-2029)
- 10.3.1 China Cell and Gene Supply Chain Solutions Market Forecast
- 10.3.2 Japan Cell and Gene Supply Chain Solutions Market Forecast
- 10.3.3 Korea Cell and Gene Supply Chain Solutions Market Forecast
- 10.3.4 Southeast Asia Cell and Gene Supply Chain Solutions Market Forecast
- 10.3.5 India Cell and Gene Supply Chain Solutions Market Forecast
- 10.3.6 Australia Cell and Gene Supply Chain Solutions Market Forecast
- 10.4 Europe Cell and Gene Supply Chain Solutions Forecast by Country (2024-2029)
- 10.4.1 Germany Cell and Gene Supply Chain Solutions Market Forecast
- 10.4.2 France Cell and Gene Supply Chain Solutions Market Forecast
- 10.4.3 UK Cell and Gene Supply Chain Solutions Market Forecast
- 10.4.4 Italy Cell and Gene Supply Chain Solutions Market Forecast
- 10.4.5 Russia Cell and Gene Supply Chain Solutions Market Forecast
- 10.5 Middle East & Africa Cell and Gene Supply Chain Solutions Forecast by Region (2024-2029)
- 10.5.1 Egypt Cell and Gene Supply Chain Solutions Market Forecast
- 10.5.2 South Africa Cell and Gene Supply Chain Solutions Market Forecast
- 10.5.3 Israel Cell and Gene Supply Chain Solutions Market Forecast
- 10.5.4 Turkey Cell and Gene Supply Chain Solutions Market Forecast
- 10.5.5 GCC Countries Cell and Gene Supply Chain Solutions Market Forecast
- 10.6 Global Cell and Gene Supply Chain Solutions Forecast by Type (2024-2029)
- 10.7 Global Cell and Gene Supply Chain Solutions Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Arvato
- 11.1.1 Arvato Company Information
- 11.1.2 Arvato Cell and Gene Supply Chain Solutions Product Offered
- 11.1.3 Arvato Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Arvato Main Business Overview
- 11.1.5 Arvato Latest Developments
- 11.2 Biocair
- 11.2.1 Biocair Company Information
- 11.2.2 Biocair Cell and Gene Supply Chain Solutions Product Offered
- 11.2.3 Biocair Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Biocair Main Business Overview
- 11.2.5 Biocair Latest Developments
- 11.3 CSafe Global, LLC
- 11.3.1 CSafe Global, LLC Company Information
- 11.3.2 CSafe Global, LLC Cell and Gene Supply Chain Solutions Product Offered
- 11.3.3 CSafe Global, LLC Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 CSafe Global, LLC Main Business Overview
- 11.3.5 CSafe Global, LLC Latest Developments
- 11.4 Catalent
- 11.4.1 Catalent Company Information
- 11.4.2 Catalent Cell and Gene Supply Chain Solutions Product Offered
- 11.4.3 Catalent Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Catalent Main Business Overview
- 11.4.5 Catalent Latest Developments
- 11.5 BioLife Solutions
- 11.5.1 BioLife Solutions Company Information
- 11.5.2 BioLife Solutions Cell and Gene Supply Chain Solutions Product Offered
- 11.5.3 BioLife Solutions Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 BioLife Solutions Main Business Overview
- 11.5.5 BioLife Solutions Latest Developments
- 11.6 BioTherapies
- 11.6.1 BioTherapies Company Information
- 11.6.2 BioTherapies Cell and Gene Supply Chain Solutions Product Offered
- 11.6.3 BioTherapies Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 BioTherapies Main Business Overview
- 11.6.5 BioTherapies Latest Developments
- 11.7 Azenta US, Inc.
- 11.7.1 Azenta US, Inc. Company Information
- 11.7.2 Azenta US, Inc. Cell and Gene Supply Chain Solutions Product Offered
- 11.7.3 Azenta US, Inc. Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Azenta US, Inc. Main Business Overview
- 11.7.5 Azenta US, Inc. Latest Developments
- 11.8 Clarkston Consulting
- 11.8.1 Clarkston Consulting Company Information
- 11.8.2 Clarkston Consulting Cell and Gene Supply Chain Solutions Product Offered
- 11.8.3 Clarkston Consulting Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Clarkston Consulting Main Business Overview
- 11.8.5 Clarkston Consulting Latest Developments
- 11.9 Cryoport
- 11.9.1 Cryoport Company Information
- 11.9.2 Cryoport Cell and Gene Supply Chain Solutions Product Offered
- 11.9.3 Cryoport Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Cryoport Main Business Overview
- 11.9.5 Cryoport Latest Developments
- 11.10 Haemonetics
- 11.10.1 Haemonetics Company Information
- 11.10.2 Haemonetics Cell and Gene Supply Chain Solutions Product Offered
- 11.10.3 Haemonetics Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Haemonetics Main Business Overview
- 11.10.5 Haemonetics Latest Developments
- 11.11 Hypertrust Patient Data Care
- 11.11.1 Hypertrust Patient Data Care Company Information
- 11.11.2 Hypertrust Patient Data Care Cell and Gene Supply Chain Solutions Product Offered
- 11.11.3 Hypertrust Patient Data Care Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Hypertrust Patient Data Care Main Business Overview
- 11.11.5 Hypertrust Patient Data Care Latest Developments
- 11.12 Lykan Bioscience
- 11.12.1 Lykan Bioscience Company Information
- 11.12.2 Lykan Bioscience Cell and Gene Supply Chain Solutions Product Offered
- 11.12.3 Lykan Bioscience Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Lykan Bioscience Main Business Overview
- 11.12.5 Lykan Bioscience Latest Developments
- 11.13 MAK-SYSTEM International Group
- 11.13.1 MAK-SYSTEM International Group Company Information
- 11.13.2 MAK-SYSTEM International Group Cell and Gene Supply Chain Solutions Product Offered
- 11.13.3 MAK-SYSTEM International Group Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 MAK-SYSTEM International Group Main Business Overview
- 11.13.5 MAK-SYSTEM International Group Latest Developments
- 11.14 MasterControl, Inc.
- 11.14.1 MasterControl, Inc. Company Information
- 11.14.2 MasterControl, Inc. Cell and Gene Supply Chain Solutions Product Offered
- 11.14.3 MasterControl, Inc. Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 MasterControl, Inc. Main Business Overview
- 11.14.5 MasterControl, Inc. Latest Developments
- 11.15 SAP
- 11.15.1 SAP Company Information
- 11.15.2 SAP Cell and Gene Supply Chain Solutions Product Offered
- 11.15.3 SAP Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 SAP Main Business Overview
- 11.15.5 SAP Latest Developments
- 11.16 SAVSU Technologies, Inc.
- 11.16.1 SAVSU Technologies, Inc. Company Information
- 11.16.2 SAVSU Technologies, Inc. Cell and Gene Supply Chain Solutions Product Offered
- 11.16.3 SAVSU Technologies, Inc. Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 SAVSU Technologies, Inc. Main Business Overview
- 11.16.5 SAVSU Technologies, Inc. Latest Developments
- 11.17 sedApta Group
- 11.17.1 sedApta Group Company Information
- 11.17.2 sedApta Group Cell and Gene Supply Chain Solutions Product Offered
- 11.17.3 sedApta Group Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 sedApta Group Main Business Overview
- 11.17.5 sedApta Group Latest Developments
- 11.18 Stafa Cellular Therapy
- 11.18.1 Stafa Cellular Therapy Company Information
- 11.18.2 Stafa Cellular Therapy Cell and Gene Supply Chain Solutions Product Offered
- 11.18.3 Stafa Cellular Therapy Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Stafa Cellular Therapy Main Business Overview
- 11.18.5 Stafa Cellular Therapy Latest Developments
- 11.19 Title21 Health Solutions
- 11.19.1 Title21 Health Solutions Company Information
- 11.19.2 Title21 Health Solutions Cell and Gene Supply Chain Solutions Product Offered
- 11.19.3 Title21 Health Solutions Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 Title21 Health Solutions Main Business Overview
- 11.19.5 Title21 Health Solutions Latest Developments
- 11.20 TraceLink, Inc.
- 11.20.1 TraceLink, Inc. Company Information
- 11.20.2 TraceLink, Inc. Cell and Gene Supply Chain Solutions Product Offered
- 11.20.3 TraceLink, Inc. Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.20.4 TraceLink, Inc. Main Business Overview
- 11.20.5 TraceLink, Inc. Latest Developments
- 11.21 TrakCel Limited
- 11.21.1 TrakCel Limited Company Information
- 11.21.2 TrakCel Limited Cell and Gene Supply Chain Solutions Product Offered
- 11.21.3 TrakCel Limited Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.21.4 TrakCel Limited Main Business Overview
- 11.21.5 TrakCel Limited Latest Developments
- 11.22 Vineti, Inc
- 11.22.1 Vineti, Inc Company Information
- 11.22.2 Vineti, Inc Cell and Gene Supply Chain Solutions Product Offered
- 11.22.3 Vineti, Inc Cell and Gene Supply Chain Solutions Revenue, Gross Margin and Market Share (2018-2023)
- 11.22.4 Vineti, Inc Main Business Overview
- 11.22.5 Vineti, Inc Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cell and Gene Supply Chain Solutions. Industry analysis & Market Report on Cell and Gene Supply Chain Solutions is a syndicated market report, published as Global Cell and Gene Supply Chain Solutions Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Cell and Gene Supply Chain Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
